A solubilization technique for photosensitizer quantification in ex vivo tissue samples.
暂无分享,去创建一个
[1] B. C. Wilson,et al. The sensitivity of normal brain and intracranially implanted VX2 tumour to interstitial photodynamic therapy. , 1996, British Journal of Cancer.
[2] Thomas H. Foster,et al. Oxygen sensitivity of PDT determined from time-dependent electrode measurements in spheroids , 1995, Photonics West.
[3] T J Dougherty,et al. A preliminary pharmacokinetic study of intravenous Photofrin in patients. , 1996, Journal of clinical laser medicine & surgery.
[4] P. D. Smith,et al. Photodynamic therapy with porphyrin and phthalocyanine sensitisation: quantitative studies in normal rat liver. , 1986, British Journal of Cancer.
[5] Q. Peng,et al. Uptake and distribution of intravenously or intravesically administered photosensitizers in the rat. , 1993, Cancer letters.
[6] M W Berns,et al. Dosimetry model for photodynamic therapy with topically administered photosensitizers , 1996, Lasers in surgery and medicine.
[7] A. Richter,et al. Tumour scanning with indium-111 dihaematoporphyrin ether. , 1990, British Journal of Cancer.
[8] A. Jain,et al. LIPOSOMAL DELIVERY OF A PHOTOSENSITIZER, BENZOPORPHYRIN DERIVATIVE MONOACID RING A (BPD), TO TUMOR TISSUE IN A MOUSE TUMOR MODEL , 1993, Photochemistry and photobiology.
[9] T J Dougherty,et al. PHOTOSENSITIZERS: THERAPY AND DETECTION OF MALIGNANT TUMORS , 1987, Photochemistry and photobiology.
[10] D. Vernon,et al. The quantitative determination of Photofrin and Polyhaematoporphyrin in plasma: pitfalls and inaccuracies. , 1995, Journal of photochemistry and photobiology. B, Biology.
[11] D. M. Burns,et al. THE MEASUREMENT OF DIHEMATOPORPHYRIN ETHER CONCENTRATION IN TISSUE BY REFLECTANCE SPECTROPHOTOMETRY , 1987, Photochemistry and photobiology.
[12] C. Gomer,et al. Clinical and preclinical photodynamic therapy , 1995, Lasers in surgery and medicine.
[13] R. Martuza,et al. Distribution of hematoporphyrin derivative in canine glioma following intraneoplastic and intraperitoneal injection. , 1986, Journal of neurosurgery.
[14] David Kessel,et al. Photodynamic therapy of neoplastic disease , 1990 .
[15] B. Wilson,et al. Absorption spectroscopy in tissue-simulating materials: a theoretical and experimental study of photon paths. , 1995, Applied optics.
[16] OPTICAL AND PHOTOBIOLOGICAL DOSIMETRY FOR PHOTODYNAMIC THERAPY OF SOLID TUMORS , 1992 .
[17] R. Zenobi,et al. Chemical analysis of cancer therapy photosensitizers by two-step laser mass spectrometry. , 1994, Analytical chemistry.
[18] B. Henderson,et al. PHOTOSENSITIZATION OF MURINE TUMOR, VASCULATURE and SKIN BY 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRIN , 1995, Photochemistry and photobiology.
[19] E. Gunter,et al. Investigation of protoporphyrin IX standard materials used in acid-extraction methods, and a proposed correction for the millimolar absorptivity of protoporphyrin IX. , 1989, Clinical chemistry.
[20] R. Sroka,et al. Photodegradation of protoporphyrin-dimethylester in solution and in organized environments. , 1993, International journal of radiation biology.
[21] Bergein F. Overholt,et al. Canine treatment with SnET2 for photodynamic therapy , 1990, Photonics West - Lasers and Applications in Science and Engineering.
[22] J Moan,et al. Binding of drugs to human plasma proteins, exemplified by Sn(IV)-etiopurpurin dichloride delivered in cremophor and DMSO. , 1993, The International journal of biochemistry.